Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Joshua Reed is recorded as CFO at Alkermes plc. (ALKS). Joshua Reed was last confirmed as Board Member at Scholar Rock Holding Corp (SRRK) in a filing dated April 11, 2025. Earlier roles on record: CFO at Aldeyra Therapeutics, Inc. (ALDX) until May 10, 2022. Alkermes plc. reported in an 8-K filed September 12, 2025 that Joshua Reed was appointed Senior Vice President, Chief Financial Officer, effective September 15, 2025. The proxy statement of Alkermes plc. reports total compensation of $3,797,074 for Joshua Reed in fiscal 2025, including a base salary of $181,978. Disclosed compensation is on record for 4 fiscal years. Joshua Reed has spoken on 12 earnings calls across 2 companies, most recently for Alkermes plc. on July 28, 2026.
“On September 12, 2025, Alkermes plc (the “Company”) announced the appointment of Joshua Reed to the position of Senior Vice President, Chief Financial Officer, effective as of September 15, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2021-01-01–2025-04-11
Last confirmed by a filing; no departure on record
Start not stated–2022-05-10
Recorded roles and call appearances connecting this person to public companies.
ALKS
CFO
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alkermes plc. (ALKS) | Senior Vice President, Chief Financial Officer | $181,978 | $3,797,074 |
| 2021 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $432,143 | $1,848,134 |
| 2020 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $382,143 | $1,688,894 |
| 2019 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $377,000 | $2,181,275 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
